# BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function

Study · id `cardio:ct-nct03646357` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03646357](<https://clinicaltrials.gov/study/NCT03646357>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03646357

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2895 participants.

## Technical summary

Registry record NCT03646357. Randomized; no masking; primary purpose treatment. Start 2018-10-01 (actual); primary completion 2025-04-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2895 participants (enrolled count; ClinicalTrials.gov record NCT03646357, source copy `cardio:ctgov-nct03646357-2025-06-08`, retrieved 2026-10-26)
- Started: 2018-10-01 (actual) (ClinicalTrials.gov record NCT03646357, source copy `cardio:ctgov-nct03646357-2025-06-08`, retrieved 2026-10-26)
- Primary completion: 2025-04-04 (actual) (ClinicalTrials.gov record NCT03646357, source copy `cardio:ctgov-nct03646357-2025-06-08`, retrieved 2026-10-26)
- Completion: 2035-12-10 (anticipated) (ClinicalTrials.gov record NCT03646357, source copy `cardio:ctgov-nct03646357-2025-06-08`, retrieved 2026-10-26)
- Countries: Norway (ClinicalTrials.gov record NCT03646357, source copy `cardio:ctgov-nct03646357-2025-06-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03646357-2025-06-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
- Acronym: BETAMI
- Condition: Acute Myocardial Infarction
- Condition: Non-ST Elevation Myocardial Infarction
- Condition: ST Elevation Myocardial Infarction
- Intervention (Other): Non-betablocker
- Intervention (Drug): Betablocker
- Lead sponsor: Oslo University Hospital
- Lead sponsor class: OTHER
- Collaborator: Vestre Viken Hospital Trust
- Collaborator class: OTHER
- Collaborator: The Hospital of Vestfold
- Collaborator class: OTHER
- Collaborator: University of Oslo
- Collaborator class: OTHER
- Collaborator: Helse Stavanger HF
- Collaborator class: OTHER\_GOV
- Collaborator: Haukeland University Hospital
- Collaborator class: OTHER
- Collaborator: St. Olavs Hospital
- Collaborator class: OTHER
- Collaborator: University Hospital of North Norway
- Collaborator class: OTHER
- Collaborator: Sorlandet Hospital HF
- Collaborator class: OTHER\_GOV
- Collaborator: Norwegian University of Science and Technology
- Collaborator class: OTHER
- Collaborator: Sykehuset Innlandet HF
- Collaborator class: OTHER
- Collaborator: Nordlandssykehuset HF
- Collaborator class: OTHER
- Collaborator: Lovisenberg Diakonale Hospital
- Collaborator class: OTHER
- Collaborator: Diakonhjemmet Hospital
- Collaborator class: OTHER
- Collaborator: Ostfold Hospital Trust
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Oslo University Hospital (`cardio:org-oslo-university-hospital`)
- Registry lists this organization as a collaborator: University of Oslo (`cardio:org-university-of-oslo`)
- Registry lists this organization as a collaborator: Haukeland University Hospital (`cardio:org-haukeland-university-hospital`)
- Registry lists this organization as a collaborator: St. Olavs Hospital (`cardio:org-st-olavs-hospital`)
- Registry lists this organization as a collaborator: University Hospital of North Norway (`cardio:org-university-hospital-of-north-norway`)
- Registry lists this organization as a collaborator: Sorlandet Hospital HF (`cardio:org-sorlandet-hospital-hf`)
- Registry lists this organization as a collaborator: Norwegian University of Science and Technology (`cardio:org-norwegian-university-of-science-and-technology`)
- Registry lists this organization as a collaborator: Nordlandssykehuset HF (`cardio:org-nordlandssykehuset-hf`)

## Provenance

Content hash: fb6c5673ee13a1a5bb46a881ae23b72631bbcdaceaadc4d552ef0ec72979f07d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
